Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib

Biochemistry (Moscow)

Volumn 73, Issue 1, 2008, Pages 29-37

  Stromskaya, T P ^a   Rybalkina, E Yu ^a   Kruglov, S S ^b   Zabotina, T N ^a   Mechetner, E B ^c   Turkina, A G ^b   Stavrovskaya, A A ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BCR ABL; Chronic myeloid leukemia; Imatinib; P glycoprotein; Tyrosine kinase inhibitor

Indexed keywords

CHEMOTHERAPY; ENZYME ACTIVITY; PROTEINS; TUMORS;

CHRONIC MYELOID LEUKEMIA; TYROSINE KINASE INHIBITOR;

CELL CULTURE;

ANTINEOPLASTIC AGENT; FLUORESCENT DYE; GLYCOPROTEIN P; IMATINIB; MULTIDRUG RESISTANCE PROTEIN; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RHODAMINE 123;

ARTICLE; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; EVOLUTION; HUMAN; METABOLISM; MORTALITY; TRANSPORT AT THE CELLULAR LEVEL;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; EVOLUTION; FLUORESCENT DYES; HUMANS; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PIPERAZINES; PYRIMIDINES; RHODAMINE 123;

EID: 43249109160     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1007/s10541-008-1004-2     Document Type: Article

References (28)